Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ct184 - clinical chemistry toxicology/drug detection ivds - detection and immunological identification (immunotyping) of snake venom in samples from bite sites, urine, plasma, blood or other tissue and body fluids.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - japanese encephalitis virus, quantity: 6 agu - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; sodium chloride; monobasic potassium phosphate; dibasic sodium phosphate; water for injections - jespect is indicated for active immunisation against japanese encephalitis (je) virus for persons 18 years of age and older. jespect should be considered for use in persons who plan to reside in or travel to areas where je is endemic (common) or epidemic (seasonal), especially during the transmission season. jespect is indicated for persons who work with je virus in laboratories and in industry.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - ibuprofen, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; arginine - caldolor injection is indicated in adults for the management of acute mild to moderate post-operative pain and moderate to severe post-operative pain with adjunctive reduced morphine dosage, where an intravenous route of administration is considered clinically necessary.,caldolor is indicated for the reduction of fever in adults where an intravenous route of administration is considered clinically necessary.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - ibuprofen, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: arginine; water for injections; hydrochloric acid - caldolor injection is indicated in adults for the management of acute mild to moderate post-operative pain and moderate to severe post-operative pain with adjunctive reduced morphine dosage, where an intravenous route of administration is considered clinically necessary.,caldolor is indicated for the reduction of fever in adults where an intravenous route of administration is considered clinically necessary.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - vibrio cholerae, quantity: 31.25 billion organisms; vibrio cholerae, quantity: 1 mg - oral liquid, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate dihydrate; water for injections; monobasic sodium phosphate dihydrate - cholera caused by serogroup 01 vibrio cholerae: active immunisation of adults and children from two years of age, who will be visiting areas epidemic or endemic for cholera and who are at high risk of infection.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - sucroferric oxyhydroxide, quantity: 2500 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; neohesperidin-dihydrochalcone; magnesium stearate; flavour - velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (ckd) on dialysis.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - sucroferric oxyhydroxide, quantity: 2500 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; neohesperidin-dihydrochalcone; magnesium stearate; flavour - velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (ckd) on dialysis.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ferric carboxymaltose, quantity: 1800 mg (equivalent: iron, qty 500 mg) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.